manufacturing Archives - Page 4 of 6 -

Eli Lilly has put a clinical trial of its COVID-19 antibody therapy on hold after FDA inspectors found

Lilly pauses COVID-19 antibody trial after factory hits trouble with FDA

https://pharmaphorum.com/news/lilly-pauses-covid-19-antibody-trial-after-factory-hits-trouble-with-fda/

Market Access/ News/ News/ Top stories

BioNTech, Lilly shore up manufacturing capacity for their COVID-19 meds

Phil Taylor antibody, BioNTech, coronavavirus vaccine, coronavirus, COVID-19, Eli Lilly, manufacturing 0 Comment

With vaccines and drugs for COVID-19 now in late-stage development, companies are moving swiftly to lay down the

BioNTech, Lilly shore up manufacturing capacity for their COVID-19 meds

https://pharmaphorum.com/news/biontech-lilly-shore-up-manufacturing-capacity-for-their-covid-19-meds/

News/ News/ R&D

Sanofi set to spin off API business late next year – report

Richard Staines api, manufacturing, Sanofi 0 Comment

Sanofi is to begin preparations in autumn to spin off its active ingredients business and is lining up a potential

Sanofi set to spin off API business late next year – report

https://pharmaphorum.com/news/sanofi-set-to-spin-off-api-business-late-next-year-report/

News/ Top stories

Gilead working with generics firms to boost global supply of COVID-19 drug

Richard Staines coronavirus, COVID-19, Gilead, manufacturing, remdesivir, supply chain 0 Comment

Gilead has outlined plans to work with generics firms to rapidly increase production of its COVID-19 drug remdesivir to meet

Gilead working with generics firms to boost global supply of COVID-19 drug

https://pharmaphorum.com/news/gilead-working-with-generics-firms-to-boost-global-supply-of-covid-19-drug/

News

Coronavirus has caused drug shortage, says FDA chief

Richard Staines coronavirus, COVID-19, drug supply, fda, generics, manufacturing 0 Comment

The FDA has announced the first drug shortage caused by the COVID-19 coronavirus outbreak, following previous warnings about

Coronavirus has caused drug shortage, says FDA chief

https://pharmaphorum.com/news/coronavirus-has-caused-drug-shortage-says-fda-chief/

Chinese people wearing surgical mask sitting in subway

News

COVID-19 could disrupt supplies of cheap generics, analysts warn

Richard Staines antivirals, coronavirus, COVID-19, generics, infectious diseases, manufacturing, Mylan, Teva, vaccine 0 Comment

An extended COVID-19 coronavirus outbreak could impact on supplies of generic drugs that many health systems rely on

COVID-19 could disrupt supplies of cheap generics, analysts warn

https://pharmaphorum.com/news/covid-19-could-disrupt-supplies-of-cheap-generics-moodys/

Digital/ News/ News/ Top stories

Novartis taps Amazon know-how for ‘smart’ manufacturing, supply chain

Phil Taylor Amazon, digital, manufacturing, Novartis, supply chain 0 Comment

Novartis has joined forces with Amazon, drawing on the online retail giant’s technological wizardry to reduce bottlenecks and

Novartis taps Amazon know-how for ‘smart’ manufacturing, supply chain

https://pharmaphorum.com/news/novartis-taps-amazons-know-how-for-smart-manufacturing-supply-chain/

Digital/ Insights/ News

Sanofi opens digital biologics manufacturing site

Richard Staines manufacturing, R&D, Sanofi 0 Comment

Sanofi has opened a manufacturing facility in the US, one of the world’s first facilities using digital continuous

Sanofi opens digital biologics manufacturing site

https://pharmaphorum.com/news/sanofi-opens-digital-biologics-manufacturing-site/

Events/ Partner content

Cell and Gene Therapy Manufacturing Forum

mike.hammerton@pharmaphorum.com cell, Forum, Gene, manufacturing, pharmaceutical, Therapy 0 Comment

Last year we told you that the cell and gene industry would be worth $9 – $14 billion

Cell and Gene Therapy Manufacturing Forum

https://pharmaphorum.com/partner-content/events-partner-content/cell-and-gene-therapy-manufacturing-forum/

Trending

manufacturing

Login